FDA NDC Directory · JSON-LD · Markdown

Vyvanse

NDC 59417-119 · HUMAN PRESCRIPTION DRUG · TABLET, CHEWABLE

Generic nameLISDEXAMFETAMINE DIMESYLATE
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA208510
Dosage form / routeTABLET, CHEWABLE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (50 mg/1)
Marketing started20170128
Package count1

External sources

Source: openFDA. Public-domain (CC0).